Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study

Publication

Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study

Journal Paper/Review - Jun 26, 2018

Salazar-Vizcaya Luisa, Rauch Andri, Béguelin Charles, Rougemont Mathieu, Hoffmann Matthias, Bernasconi Enos, Stoeckle Marcel, Cavassini Matthias, Braun Dominique, Fehr Jan, Wandeler Gilles, Swiss HIV Cohort Study

Citation

Salazar-Vizcaya L, Rauch A, Béguelin C, Rougemont M, Hoffmann M, Bernasconi E, Stoeckle M, Cavassini M, Braun D, Fehr J, Wandeler G, Swiss HIV Cohort Study. Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study. Open Forum Infect Dis 2018; 5:ofy154.

Type

Journal Paper/Review (English)

Journal

Open Forum Infect Dis 2018; 5

Publication Date

Jun 26, 2018

Issn Print

2328-8957

Pages

ofy154

Brief description/objective

In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C virus (HCV) infection decreased substantially after the introduction of direct-acting antivirals (DAAs). Among men who have sex with men, the increase in DAA uptake and efficacy was counterbalanced by frequent incident HCV infections.